
Lenovo and Ericsson have reached a global patent cross-licensing agreement, bringing an end to their long-standing legal battle over wireless technology patents. The settlement, announced by Lenovo on Thursday, resolves multiple lawsuits filed by both companies across several countries.
According to Reuters, Lenovo initiated legal action against Ericsson in London in 2023. This case was one of many filed worldwide, with litigation also taking place in Brazil, Colombia, the United States—including North Carolina and the U.S. International Trade Commission. The disputes revolved around the terms for licensing 4G and 5G patents, specifically whether they adhered to fair, reasonable, and non-discriminatory (FRAND) principles.
Per Reuters, Lenovo stated that as part of the settlement, both parties had agreed to binding arbitration to determine the final terms of the licensing agreement. Ericsson also confirmed the resolution, noting that financial implications from the agreement would begin to be recognized from the second quarter of 2025, reflecting a partial settlement.
This agreement follows a similar move by Amazon and Nokia earlier in the week, in which those companies also resolved a global patent dispute. The series of settlements highlight an industry-wide shift toward resolving intellectual property conflicts outside of the courtroom.
Related: Lenovo Bets on AI as South Korea Grants Banks Access to Cloud Computing
Source: Reuters
Featured News
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Microsoft Nears EU Antitrust Resolution Over Teams Bundling, Sources Say
May 14, 2025 by
CPI
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas